16
Amsterdam-based agri-food investor Anterra Capital has closed €86 million, or about $100 million, for the first tranche of its third fund. That puts it halfway to its €172.1 million, or $200 million, target.
The June 15, 2026 close was backed by a mix of institutional investors, food system operators, and industry heavyweights from North America, Europe, and APAC. LPs include Rabobank, Novo Holdings, and Zoetis. Together, the operator LPs farm over 13 million acres and run some of the world’s biggest CPG, bakery, produce logistics, and retail businesses.
“Having global asset managers, sector experts, and the people who actually farm millions of acres all backing the same thesis is unmatched,” said Adam Anders, Partner at Anterra.
Launched in 2013, Anterra invests in life-science and software startups that improve food and agriculture. The firm now manages over €430.4 million, or $500 million, across three funds.
Anterra argues the timing is right. Food and agriculture is still the world’s largest industry, worth roughly €8.6 trillion, or $10 trillion, and employing 1.3 billion people. But venture funding cooled after 2021’s record €44.7 billion, or $52 billion, year. Much of that money went to capital-intensive bets like vertical farms, plant-based meat, and 10-minute grocery delivery that failed to scale.
The firm is now betting on “science-backed” companies with real unit economics that can plug into existing supply chains.
We are excited to share with you
This FREE E-Book of 50 Agritech Pioneers & Their Game Changing Innovations.
Download the Ebook now
“The past two capital cycles rewarded discipline,” said Maarten Goossens, Partner. “What’s new is that agriculture, which has resisted software for decades, is finally ready to be rewired. The AI tools are here.”
Anterra says AI is hitting hardest in industries the last software wave missed. In food and ag, it’s digitizing manual workflows and fragmented data. In biology, AI is cutting R&D time, team size, and capital needed to reach a first commercial milestone.
Fund III has already made two bets: Anchr, an AI-native platform for food distribution built with a16z Speedrun, and Animerra, a veterinary biologics company founded in-house by Anterra.
The firm points to its track record. Fund I and II produced multiple exits, including one of the largest early-stage veterinary medicine deals ever, a Nasdaq IPO, and strategic acquisitions. Anterra also incubated Enko Chem, which develops new crop-protection chemistry with partners like Syngenta and Bayer, and Invetx, which was sold to Dechra Pharmaceuticals for over €430.3 million, or $500 million, six years after launch.
Read Also: Chunk Foods Bets on Lean Fermentation and Protein Hype to Hit Profitability by 2027
“We’ve spent 12 years proving you can build category-defining ag companies and generate real returns,” said Brett Wong, Partner. “Now the tech, valuations, and founders are all aligned. Fund III is how we scale that.”
